| 000 | 01512 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513053432.0 | ||
| 264 | 0 | _c19941221 | |
| 008 | 199412s 0 0 eng d | ||
| 022 | _a0277-3732 | ||
| 024 | 7 |
_a10.1097/00000421-199412000-00014 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTsavaris, N | |
| 245 | 0 | 0 |
_aComparison of ondansentron (GR 38032F) versus ondansentron plus alprazolam as antiemetic prophylaxis during cisplatin-containing chemotherapy. _h[electronic resource] |
| 260 |
_bAmerican journal of clinical oncology _cDec 1994 |
||
| 300 |
_a516-21 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlprazolam _xadministration & dosage |
| 650 | 0 | 4 |
_aCisplatin _xadverse effects |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNausea _xchemically induced |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aOndansetron _xadministration & dosage |
| 650 | 0 | 4 |
_aVomiting _xchemically induced |
| 700 | 1 | _aCharalambidis, G | |
| 700 | 1 | _aPagou, M | |
| 700 | 1 | _aKarabelis, A | |
| 700 | 1 | _aMylonakis, N | |
| 700 | 1 | _aBacoyiannis, C | |
| 700 | 1 | _aKosmidis, P | |
| 773 | 0 |
_tAmerican journal of clinical oncology _gvol. 17 _gno. 6 _gp. 516-21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00000421-199412000-00014 _zAvailable from publisher's website |
| 999 |
_c7976503 _d7976503 |
||